Genomic enhancers form the central nodes of gene regulatory networks by harbouring combinations of 27 transcription factor binding sites. Deciphering the combinatorial code by which these binding sites are 28 assembled within enhancers is indispensable to understand their regulatory involvement in establishing 29 a cell's phenotype, especially within biological systems with dysregulated gene regulatory networks, 30 such as melanoma. In order to unravel the enhancer logic of the two most common melanoma cell states, 31
Introduction 42
A cell's phenotype arises from the expression of a unique set of genes, which is regulated through the 43 binding of transcription factors (TFs) to cis-regulatory elements, such as promoters and enhancers. 44
Deciphering gene regulatory programs entails understanding the network of transcription factors and 45
cis-regulatory elements that governs the identity of a given cell type; as well as understanding how the 46 specificity of such a network is encoded in the DNA sequence of genomic enhancers. Enhancers harbor 47 combinations of binding sites for TFs, through which transcription of nearby target genes is regulated 1, 2 . 48
The chromatin around enhancers is typically enriched for acetylation of histone H3 at lysine 27 49 (H3K27ac) and H3 monomethylation at K3 (H3K4me1), allowing enhancer identification through 50
ChIP-seq for these specific histone marks 1 . In addition, profiling accessible chromatin via DNase I 51 hypersensitive sequencing (DNase-seq) or via the Assay for Transposase-Accessible Chromatin using 52 sequencing (ATAC-seq) represents a useful approach for identifying putative enhancers 3, 4 . Indeed, 53
active enhancers are typically depleted of one or more nucleosomes, due to the binding of TFs. Initial 54 changes in DNA accessibility can be facilitated through a special class of TFs that bind with high 55 affinity to their recognition sites and that have a long residence time at the enhancer; sometimes referred 56
to as pioneer TFs 4,5 . By displacing nucleosomes or thermodynamically outcompeting nucleosome 57
binding they allow other TFs to co-bind, thereby further stabilising the nucleosome depleted region 58 and/or actively enhancing transcription of target genes 6,7 . As the presence and architecture of TF binding 59 sites within enhancers determine which TFs can bind with high affinity, understanding this 'enhancer 60
logic' can help interpreting the functional role of enhancers within a gene regulatory network. Several 61 techniques exist to study the enhancer code, including (1) motif discovery tools, in which position-62
weight matrices of TF binding sites are used to calculate their enrichment in sets of co-regulated regions particular enhancer architectures, and whether such architectures are evolutionary conserved. Besides 89 human cell lines and human patient-derived cultures, several animal models have been established in 90 melanoma research, including mouse, pig, horse, dog and zebrafish [30] [31] [32] [33] [34] . Although these models are 91 widely used, it is unknown whether their enhancer landscapes and regulatory programs are conserved 92 with human. 93 94
Here, we combine comparative regulatory genomics with machine learning to investigate enhancer 95 logic in melanoma. Through epigenomic profiling of 27 melanoma cell lines across six species, we 96 examine the conservation of the two main melanoma states and underlying master regulators. By 97 training a deep neural network, called DeepMEL, on topic models derived from the human cell lines, 98
we were able to classify not only human melanoma enhancers, but also regulatory regions in the other 99 species. DeepMEL revealed high-confidence TF binding sites for the different melanoma states, how 100 they are positioned within melanoma enhancers, and where they are placed with respect to the central 101 enhancer nucleosome. This in-depth analysis of the melanoma enhancer code allowed us to propose a 102 mechanistic model of TF binding in MEL melanoma enhancers. Finally, by exploiting the deep layers 103 of our model, we are able to identify causal mutations for melanoma enhancer loss and gain through 104 evolution, not only affecting enhancer accessibility but also activity. 105 globally conserved regions (Fig. 1e, Fig. S1f ), revealed again two main clusters . One cluster contained 151 all human MEL samples together with 9 of the 10 non-human lines, indicating that most of the non-152 human cell lines are epigenomically similar to human MEL lines. On the other hand, the second cluster 153 consisted of all human MES samples together with the dog cell line 'Bounty'. Based on this co-154 clustering of melanoma lines, we can state that all non-human cell lines are in the MEL state, except 155
for the dog line 'Bounty' which belongs to the MES state. Indeed, known MEL regulatory regions such 156
as the intronic enhancer of MLANA, a MEL-specific gene involved in melanosome biogenesis 43 , are 157 accessible in all mammalian lines, except for the MES human lines and the dog line Bounty; whereas 158 the opposite is true for an enhancer upstream of MMP3, a gene which increases metastatic potential in 159 melanoma cell lines 44 (Fig. 1f ). 160 161
In conclusion, by using ATAC-seq on a panel of 27 melanoma lines across six species, conserved 162 regulatory regions could be identified. These regions allowed clustering of the melanoma samples into 163 two groups which correspond to the two main melanoma cell states, indicating conservation of the MES 164 melanoma state in dog and the MEL melanoma state in pig, mouse, horse, dog and even zebrafish 165 melanoma samples. Conserved transcription factor motifs determine state-specific enhancers 183 Next, we wanted to investigate whether the conserved MEL and MES states are controlled by similar 184 master regulators across different species. First, we performed an evolutionary comparison of 185 differential transcription factor binding sites between MEL and MES cell lines in human and dog, as 186
these were the only two species in our cohort for which cell lines of both states were available. 187
Differential peak calling between the human MEL and MES lines revealed significant enrichment of 188 SOX, TFAP2, MITF, RUNX and ETS TF binding motifs in the 25,164 differential MEL human peaks 189 (log2FC > 2.5 and pAdj < 0.0005; complete Homer output in Supplementary Table 1) ( Fig. 2a) . Indeed, 190 SOX10, TFAP2 and MITF are among the previously reported master regulators of the MEL state 24,27-191 29 . The 12,824 human differential MES regions were significantly enriched for binding motifs for 192 transcription factors of the AP-1 family and TEADs ( Fig. 2a To further verify the importance of the MEL-specific master regulators in MEL cell lines of the 206 remaining four species, we applied a different strategy since we could not contrast MEL and MES lines 207 for horse, pig, mouse and zebrafish. Therefore, we focused on 9,732 regions that were conserved across 208 all mammalian MEL lines to identify conserved TF binding sites. Note that this number differs from 209 the 10,592 conserved regions defined above as only the MEL lines were used here. We scanned the 210 9,732 conserved regions using our library of 20,003 TF position-weight matrices (PWMs) and used a 211 branch length score (BLS) to calculate the level of evolutionary conservation of each TF binding motif 212 ( Fig. 2c ), a strategy applied before in other systems 7,45 . Among the 4% most conserved motifs were 213 SP1, ETS, SOX (both monomer and dimer motifs), CTCF, MITF and TFAP2 motifs ( Fig. 2d ). Notably, 214
the top conserved motifs were members of the SP/KLF TF family, which bind to GC-rich motifs in 215 promoters 46 . Indeed, 47% of the 9,732 conserved regions in mammalian MEL lines were proximal 216 promoters (<= 1 kbp from TSS). BLS scoring on the remaining 5,196 more distal conserved regions 217 showed no longer conservation SP1/KLF TF motifs, but just conservation of the previously identified 218 TF binding motifs for TFAP2A, MITF, SOX10, CTCF and ETS factors ( Fig. S1i ), indicating that distal 219 regions, such as enhancers, mostly contain the state-specific TF binding motifs. Interestingly, when we 220
included zebrafish ATAC-seq regions, only 113 regions were conserved in the MEL cell lines across 221 all six species, but BLS scoring still revealed SOX, ETS, MITF and TFAP2 motifs among the most 222 conserved motifs in MEL lines ( Fig. 2e ). Note that we did not perform any contrast of MEL versus 223
MES lines prior to the BLS analyses and that these motifs were identified by just focusing on the 224 conserved regions in MEL melanoma lines.
226
Altogether, two independent strategies of motif analysis suggest that melanoma enhancer logic is 227
conserved across species and that the MEL state is governed by conserved master regulators including 228 SOX10, MITF, TFAP2A and ETS. 
232
Heatmap of differential ATAC-seq regions when comparing (a) human MEL versus human MES lines and (b) 233 the MEL dog line 'Cesar' versus the MES dog line 'Bounty' (two biological replicates each), coloured by 234 normalised ATAC-seq signal. Enriched TF binding motifs in the differential peaks were identified via Homer 47 235 and the first logo of enriched TF families is shown. The ratio of the percentage of target sequences with the motif 236 and the percentage of background sequences with the motif is indicated between brackets, as well as the rank of 237 the TF class within the Homer output (#). c, Schematic overview of cross-species motif analysis using the branch 238 length score (BLS) as a measure for the evolutionary conservation of a motif hit (for 20,003 TF position-weight 239 matrices) across conserved regions. The BLS was summed across a set of conserved regions, i.e. the higher the 240 BLS score, the more conserved the motif is in that specific set of regions. d, e, Histogram of the normalised 241 summed BLS score for 20,003 motifs on (d) 9,732 conserved regions across the mammalian MEL lines and on 242 (e) 113 conserved regions across MEL lines of all six species. The first hit of the top recurrent TF binding motifs 243 within the top 4% conserved motifs is indicated as a cross and is accompanied by the logo of the motif.
244

Deep neural network DeepMEL reveals nucleotide-resolution enhancer logic
245 While motif enrichment can predict candidate regulators, we sought to build a more comprehensive 246 model of the MEL enhancers, that would allow cross-species predictions and in-depth analysis of 247 enhancer architecture. To this end, we trained a deep learning (DL) model on human ATAC-seq data.
248
First, to construct an unsupervised training set, we clustered all 339,099 human ATAC-seq peaks using 249 cisTopic 48 (see Methods) into 24 topics ( Fig. 3a, Fig. S2a,b ). This provided a more nuanced 250 classification, with topic 4 representing the MEL enhancers being accessible across all MEL samples; 251 and topic 7 representing the MES enhancers that are accessible in the MES samples ( Fig. 3a, Fig. S2c ).
252
In addition, we found two topics containing regions that are generally accessible across all cell lines 253
(topic 1 and topic 19) ( Fig. 3a, S2c ), and which were highly enriched for proximal promoters (Fig. S2d ) 254
and for known promoter-specific TF binding motifs linked to SP1 and NFY TF families ( Fig. S2c ) 46, 49 . 255
Other topics were more specific to one or a small group of cell lines. For instance, topic 22 contained 256 regions that were mostly accessible in MM057, MM074 and MM087 (Fig. 3a) . These particular lines 257 have previously been reported as an 'intermediate' (INT) sub-state of the MEL state, governed by a 258 mixed MEL-MES GRN 28 . We verified the biological relevance of these topics by investigating nearby 259 target genes using GREAT 50 . Genes near topic 4 regions are significantly enriched for Gene Ontology 260
(GO) terms such as pigmentation (FDR=1.95e-8) and neural crest cell differentiation (FDR=4.26e-7), 261
whereas genes near topic 7 regions were more mesenchymal-like as they are enriched for GO terms 262
involved in cell-cell adhesion (1.56e-13). Next, we performed motif discovery on the top regions 263 assigned to each topic. SOX, ETS, TFAP2 and MITF motifs were enriched in regions of the MEL-264 specific topic 4 and AP-1 in the MES-specific topic 7 ( Fig. S2c ), confirming our findings from the 265 supervised differential peak calling discussed above ( Fig. 2a ). An example topic 4 region in the 266 promoter of the SOX10 target gene MIA 51 is shown in Figure 3b , as well as two topic 7 regions upstream 267 of SERPINE1, a gene expressed in metastatic melanoma 52 . 268 269
Using the 24 topics as classes, we trained a multi-class, multi-label classifier using a neural network, 270
called "DeepMEL" (Fig. 3c ). As input, we used the forward and reverse complement of 500 bp enhancer 271 sequences centered on the ATAC-seq summit. As topology, we used the DanQ CNN-RNN hybrid 272 architecture 53 consisting of 4 main layers: a convolution layer to discover local patterns in sequential 273 data, followed by a max-pooling layer to reduce the dimensionality of the data and generalise the model 274 effectively, a bidirectional recurrent layer (LSTM) to detect long-range dependencies of the local 275 patterns discovered in the first layer, and finally a fully-connected (dense) layer just before the output 276 layer to help the classification after the feature extraction layers ( Fig. 3c ). After successful training of 277
DeepMEL (auroc = 0.863 and aupr = 0.374 on test data for topic 4 regions) ( Fig. 3d ,e, Fig. S3a ), we 278 used the weights of neurons from the convolutional filters to extract local patterns learned by the model.
279
We transformed these convolution filters into PWMs and found the importance of each filter for each 280 topic (see Methods and Supplement). Intriguingly, filters that represent SOX, MITF, TFAP, and RUNX 281 motifs were most relevant for the MEL-specific topic 4 and filters that represent AP-1, TEAD and 282 RUNX binding sites were assigned to the MES-specific topic 7 ( Fig. 3f ). Thus, DeepMEL learned the 283 relevant features de novo from the sequence. DeepMEL can be used to score and classify any given 284
DNA sequence of 500 bp. For instance, when re-entering all ATAC-seq peaks of the MEL line MM001 285 in the model, it classified 3,885 regions as MEL-specific (topic 4 scores above threshold of 0.16 (see 286
Methods)). These regions were indeed highly accessible in MEL lines and closed in MES lines, and 287 interestingly, were also accessible in human melanocytes (Fig. S3b,c) . Importantly, this indicates that 288 these MEL-specific regions in melanoma are not cancer-specific but already accessible in their cell-of-289 origin, i.e. the melanocytes, and that we potentially can extrapolate the observations on this topic to 290 melanocyte enhancers. Although in the remainder of this work we will score accessible regions to 291 identify functional enhancers, it is also possible to score the entire genome, without filtering for ATAC-292 seq peaks. This may be useful for species where no ATAC-seq data of melanoma or melanocytes is 293 available. Such a scoring yields high precision and recall (69% and 86% respectively, Fig. S3d ).
295
In order to examine the TF binding site architecture within enhancers, we used a model interpretation 296
tool, DeepExplainer 54,55 , which does backpropagation of the activation differences 56 , to visualise the 297 importance of each nucleotide in an enhancer with respect to the predicted enhancer class. For instance, 298 in a MEL enhancer located on the 4th intron of IRF4, nucleotides important for classifying this enhancer 299
as topic 4 form motifs for SOX10, MITF, TFAP and RUNX factors ( Fig. 3g top two rows). Indeed, 300
SOX10 binding has been reported on this location 57 . Another example is given for a region of topic 22, 301 the topic specific to the INT MEL subpopulation, where SOX10 and AP-1 co-exist within the same 302 enhancer, indicating that these cell lines also contain properties of a mixture between the MEL and 303 MES state at the epigenomic level ( Fig. S3e,f) .
Importantly, it is known that enhancer accessibility does not directly translate to enhancer activity 1 . To 306 test whether the same TF binding motifs were contributing to the activity of MEL enhancers, we used 307
the IRF4 enhancer as case study. For this enhancer, Kircher et al. 14 performed saturation mutagenesis 308 followed by an in vitro massively parallel reporter assay (MPRA), testing the effect of every possible 309 single nucleotide mutation on enhancer activity ( Fig. 3g , 3th row). The most deleterious mutations 310 coincided with the SOX, E-box and RUNX-like motifs that were predicted by DeepMEL, indicating 311
that the predicted motifs are also contributing to enhancer activity, as their disruption reduced enhancer 312 activity in vitro. To further examine how well DeepMEL can predict the in vitro MPRA effect, we 313 measured the effect on the topic 4 DL score of each single nucleotide mutation in silico (Fig. 3g , bottom 314 row). Interestingly, mutations that have the strongest in silico effect overlapped with predicted TF 315
binding motifs, and more intriguingly, also the magnitude of the effect highly correlated with the in 316 vitro mutations (Spearman correlation of 0.60) ( Fig. 3g ,h), even though DeepMEL was trained only on 317 binary accessibility data (i.e. binary topics of co-accessible regions). These observations indicate that, 318
although the DeepMEL was trained to predict enhancer accessibility, it is also a good predictor of 319 enhancer activity of this specific enhancer. Notably, our DeepMEL performed best in predicting the in 320 vitro mutagenesis on the IRF4 enhancer activity compared to other classifiers and deep learning models 321 that were benchmarked in Kircher et al. 14 (CAGI challenge, 2018) ( Fig. 3i ). Interestingly, enhancer 322 accessibility and activity were not only influenced by mutations that break a motif for an activating TF, 323
but also by the creation of a repressor binding motif. This was the case for a C-to-T mutation that 324
coincided with a SNP involved in freckles, brown hair and high sensitivity of the skin to sun exposure 325 (rs12203592, SNPedia) ( Fig. 3g ). This SNP creates a ZEB/SNAI-like motif that negatively contributes 326
to the MEL topic score of this enhancer ( Fig. S3g ). A similar motif was also found to decrease the MEL 327 prediction in the wild-type sequence ( Fig. 3g , "ZEB", letters facing downwards) and mutating this motif 328 increased the topic 4 prediction score, indicating that the ZEB/SNAI-like TF binding motif (CAGGT) 329 may function as a repressor for the MEL state. Indeed, ZEB factors have been reported to act as 330 transcriptional repressors by interaction with the corepressor CtBP 58 , and mutations in the binding motif 331 of the transcriptional repressor SNAI2 have been shown to increase chromatin accessibility 11 . Note that 332 the ability of DeepMEL to predict the effect of mutations on enhancer accessibility (and activity) raises 333 the opportunity to apply DeepMEL to predict enhancer mutations that affect chromatin accessibility in, 334
for instance, personalised cancer genomes; as we did in our companion paper for phased melanoma 335
genomes of a total of 10 patient-derived melanoma cultures (Kalender Atak et al., 2019). 336 337
In conclusion, our DL model DeepMEL, trained on topics of human co-accessible regions, is performant 338 in classifying melanoma regulatory regions into different classes based on purely the DNA sequence. 339
Interestingly, features learned by DeepMEL corresponded to TF binding motifs of master regulators of 340 specific classes. These motifs could also be located and visualised within regions using a model 341 interpretation tool, allowing examination of the motif architecture within specific enhancers and 342
predicting the effect of mutations on enhancer accessibility. 343 
363
Cross-species scoring identifies orthologous melanoma enhancers 364
Next, we wanted to use the human-trained DL model DeepMEL for predicting MEL and MES 365 enhancers in other species. We started with the dog genome as a test case, because the differential 366
ATAC-seq peaks between the MEL (Cesar) and MES (Bounty) dog cell lines could be used as true 367
positives. DeepMEL reached an area under the receiver operating characteristic (auroc) of 0.979 for 368
predicting MEL regions (as topic 4) versus MES regions (as topic 7) in dog, which approximates the 369 model's performance for classifying human MEL and MES differential regions (auroc = 0.987), and 370 this accuracy is significantly higher compared to using cis-regulatory module (CRM) scoring with 371
PWMs (Fig 4a,b ,c). Having confirmed that the human model can identify enhancers in the dog 372 epigenome, we predicted MEL and MES enhancers across all six species. This yielded between 2,093 373
and 5,400 MEL enhancers, and between 7,459 and 10,743 MES enhancers, in samples of the MEL and 374
MES state respectively ( Fig. 4d, S4c ). Interestingly, although the total number of accessible regions in 375
the genome varies between cell lines and species (Fig. 4d , numbers between brackets), for all MEL cell 376 lines around 2.5% of the accessible regions were predicted MEL enhancers. Note that the majority of 377 these enhancers could not have been detected using whole genome alignments (liftOver) ( Fig. 4b ,c, Fig  378 S4a-d).
380
Having identified high-confidence MEL enhancers genome-wide across 6 species, as a combination of 381 ATAC-seq peaks and high topic 4 prediction scores, we analysed their distribution with respect to 382 orthologous genes, and their evolutionary divergence. Particularly, we looked at enhancers located near 383 a set of 379 human genes that are specifically expressed in the MEL state (derived from RNA-seq data 384 across a cohort of twelve MM lines (see Methods)). Of these 379 genes, 217 (67%) had at least one 385 MEL-predicted enhancer within a locus of 200kb up-and downstream of the gene (the MEL cell line 386 MM001 was used for this analysis). Between 70-85% of the orthologous MEL genes in other species 387 had at least one MEL enhancer nearby ( Fig. S4e ). Note that only a small subset of these enhancers could 388
have been found using liftOver (2-43% depending on the species). Of these genes, 32 form a core set 389
of conserved genes throughout all species, each having a MEL enhancer, including zebrafish. Examples 390 of genes in the core set are MITF, PMEL and TYRP1, genes known to be involved in melanocyte 391 development, melanosome formation and melanin production 60 . 392 393
A long-standing question in enhancer studies is how to compare enhancers with each other, if their 394 sequences do not align 61,62 . Here we tackle this question by using the dense layer of DeepMEL as a 395
reduced dimensional space to calculate the correlation between enhancers. Using this measure we found 396 that MEL-predicted enhancers in proximity of homologous MEL genes are significantly more similar 397
to each other compared to MEL-predicted enhancers in proximity of different MEL genes within the 398 same species (Fig. 4e ), indicating that MEL enhancers near orthologous genes are indeed orthologous 399 enhancers. Note that the correlation of orthologous MEL enhancers approximated or even surpassed the 400 correlation of redundant (or shadow enhancers 63 ) linked to the same MEL gene in a species (Fig. S4f) . 401
Lastly, we studied an example of a MEL enhancer in more detail, namely the enhancer near ERBB3. 402
DeepMEL predicts a MEL enhancer upstream or intronic of ERBB3 in each of the mammalian species, 403 which were also found by liftOver of the human ERBB3 enhancer ( Fig. 4f II) . However, in the zebrafish 404 genome, liftOver was unable to identify the homologous region, whereas DeepMEL predicted two MEL 405 enhancers, one upstream of the TSS of erbb3b and another in the first intron. Both zebrafish enhancers 406
were highly correlated with the human ERBB3 enhancer (deep layer pearson correlation of 0.812 and 407 0.797 for the upstream and intronic zebrafish enhancer, respectively), suggesting that both enhancers 408 are orthologous to the human ERBB3 enhancer. Applying DeepExplainer to the multiple-aligned 409 sequences revealed a conserved motif architecture in the orthologous mammalian ERBB3 enhancers 410
containing each three SOX motifs and one TFAP2 motif ( Fig. 4f III) . Note that in mouse, one SOX 411
binding site was lost, mouse is also the mammalian species that is most distant from human, among the 412 included species in this study ( Fig. 4f I) . The two zebrafish enhancers contain several SOX motifs, 413
however with different inter-motif distances. The two zebrafish enhancers have a highly similar motif 414
architecture, suggesting that they arose by duplication from a common ancestor enhancer. 415 416
In conclusion, we showed that DeepMEL is able to identify MEL-and MES-specific enhancers in 417 different species, which allows studying evolutionary events and enhancer logic within orthologous 418 enhancers, even in distant species such as zebrafish. 419 420 421 To study the architecture of MEL enhancers in more detail, including motif composition, motif order 442
and distance, and relationships to the nucleosome position, we set out to obtain high-confidence motif 443
annotations in each of the 3,885 MEL enhancers in human (MM001, the most MEL-like human cell 444 line), for each of the predicted core regulatory factors (SOX10, MITF, TFAP2A, RUNX). To achieve 445 this, we devised an improved motif scoring method that obtains precise positions of TF binding motifs 446 by multiplying DeepMEL activation scores of convolutional filters (i.e. motifs) with the DeepExplainer 447 profile on each enhancer ( Fig. 5a ) 64 . A motif hit is predicted as significant when its importance is above 448 a motif-specific threshold which was determined by using all regions as background (see Methods). 449 450
The first remarkable observation was that each MEL enhancer contains at least one SOX10 motif hit, 451
and often two or more (Fig 5b) . This suggests that SOX10 plays a central role in MEL enhancer 452 accessibility. Indeed, knock-down of SOX10 in MM001 significantly decreases the accessibility of 453 MEL enhancers (Fig. S5a) , and the regions that close after SOX10-KD are highly enriched for SOX 454 motifs (NES = 28.5), possibly revealing a pioneering-role of SOX10 in MEL enhancers. Pioneer factors 455
can access their binding sites on nucleosomal DNA, thereby directly or indirectly displacing the 456 nucleosome, which results in the accessibility of the region 5 . Next to SOX, a combination of one or 457 multiple TFAP2, MITF or RUNX-like motifs was present in 84% of the MEL-predicted enhancers. To 458 facilitate a systematic study of the MEL enhancer logic, we binarised the motif-region matrix to simplify 459 the region clustering (Fig 5c) . We obtained 8 different enhancer classes, each with a different motif 460 composition ( Fig. 5c ). As validation of the clusters and the predicted TF binding sites, we used human 461
ChIP-seq data of SOX10, MITF and TFAP2A in melanoma or melanocytes 65,66 ( Fig. 5d ). All clusters 462
were indeed highly bound by SOX10, validating the prevalent SOX10 motif in all MEL enhancers. In 463 contrast, MITF ChIP-seq data revealed that MITF binds more to enhancer classes with MITF motifs 464 compared to regions lacking a significant MITF motif. Similarly, only enhancers containing at least one 465 TFAP2 motif were bound by TFAP2A. Interestingly, regions containing a TFAP2A motif, next to the 466 SOX10 motif(s) and possible others, showed a modest increase in accessibility ( Fig. 5e ), which could 467 be in line with the previously described role of TFAP2A as a stabiliser of nucleosome-depleted regions 6 . 468
The opposite was true for regions containing RUNX-like TF binding sites, as these were found to be 469
less accessible compared to regions containing only SOX10 motifs, suggesting a repressive role of 470 RUNX factors. The presence of a MITF site did not seem to alter the accessibility of enhancers 471
compared SOX-only enhancers, but did increase H3K27ac signal (Fig. S5b ), possibly indicating that 472 MEL enhancers bound by MITF are more active.
474
To validate these MEL enhancer classes in other species, we applied the same motif scoring and 475 binarisation to DeepMEL-predicted MEL regions in the other species in our cohort. Interestingly, MEL 476 enhancers in other species also clustered into the same 8 clusters, with a similar distribution of regions 477
per cluster ( Fig. 5f,g, Fig. S5c ). To test the conservation of the clusters, we used liftOver to compare 478 the classification of enhancers across species. Although identifying orthologous sequences via whole 479 genome alignment is not always correct, as shown above, a general trend was observed where the 480 regions of a human cluster correspond to the same cluster in the other species (Fig. S5d) , indicating 481 conservation of the MEL enhancer clusters across species. For instance, the dog-orthologs of two human 482
MEL enhancers belonging to either the cluster containing SOX10 and MITF binding sites (intronic 483 enhancer of CD9) or to the cluster containing SOX10, TFAP2A and RUNX-like motifs (intronic 484 enhancer of STIM1) (Fig. 5f) were part of the corresponding clusters in dog (Fig. 5g ). In these examples 485
we observed preserved spacing of around 80 bp between the two SOX10 binding sites within the 486 enhancers, to which we will come back further below. 487 488
Altogether, these data suggest a COre Regulatory Complex (CoRC) 67 of SOX10, TFAP2A, MITF and 489
RUNX factors in regulating melanoma MEL enhancers, encoded by a mixed enhancer model 68 , with 490
high flexibility in the combination of binding sites for these four TFs, but with some rigidity (or 491 hierarchy) in the code as at least one SOX10 binding site is required. As previous results suggested a pioneering and stabiliser function for SOX10 and TFAP2A respectively, 511
we wanted to further investigate these putative roles and how they are mechanistically affecting 512 chromatin accessibility. First, we analysed the location of binding sites relative to the position of the 513 nucleosome, focusing on MEL enhancers that contain a combination of SOX10 and TFAP2A sites ( Fig.  514 6a,b). We predicted the nucleosome start and middle point using a previously published model 69 .
515
Interestingly, we observed that SOX10 binding sites are situated within the borders of the nucleosome, 516
near the former nucleosome start point, whereas TFAP2A binding occurs preferentially near the center 517 of the nucleosome (Fig. 6a,b ). Note that KD of TFAP2A halved the accessibility of this specific human 518 region, whereas SOX10-KD completely abolished the ATAC-seq peak (Fig. 6a ), indicating that SOX10 519
is necessary for accessibility, and that TFAP2A further increases the accessibility, which is in line with 520 our previous observations (Fig. 5e, S5a ). 521 522
These example enhancers raised an interesting positional preference of SOX10 and TFAP2A. To assess 523
whether this occurs globally we centered human MEL enhancers on the SOX10 and TFAP2A motif hits 524
and calculated the aggregated location of the nucleosome start and middle point ( Fig. 6c,d,e ). 525
Interestingly, SOX10 had a consistent preference for binding within the nucleosome borders, around 40 526 bp away from the nucleosome start point (Fig. 6c,d ). Since in chromatinised DNA, 146 bp of DNA 527 sequence is wrapped around the nucleosome, we anticipated the nucleosome middle point to be situated 528 ~35 bp (= 146 bp / 2 -40 bp) away from the SOX10 motif, which was indeed the case (Fig. 6e ). Other 529 pioneering factors have also been shown to bind near the borders of the nucleosome, such as FOX 530
factors which bind around 60 bp from the center of the nucleosome, displacing linker histones and 531
destabilising the central nucleosome 6,70 . On the other hand, when centering the MEL regions based on 532
the TFAP2A motif, we did not observe a strong preference in the location of the nucleosome start point 533
relative to the TFAP2A binding site (Fig. 6d ), but in fact TFAP2A was consistently binding in a wide 534 range on and around the nucleosome middle point (Fig. 6e) . Stabilisators, such as NFIb, are known to 535 directly compete with the central nucleosomes to stabilise the accessible chromatin configuration 6,71 . 536
Centering based on the SOX10 motif hit revealed protection of Tn5 cutting on the conserved nucleotides 537 of the dimer (Fig 6f,g) . Similarly, protection and conservation was observed on important nucleotides 538 in the TFAP2A dimer. We did not observe strong positional preferences of MITF and RUNX motifs 539
relative to the nucleosome start or middle point (Fig. S6 ). 540 541
Altogether these data highly suggest that SOX10 functions as a pioneer in the CoRC of MEL enhancers, 542 leading to their accessibility by binding to the central nucleosome, near the nucleosome start point. On 543 the other hand, TFAP2A appears to act as stabiliser of SOX-dependent nucleosome depleted regions by 544 binding around the nucleosome middle point, possibly going in competition with the central 545 nucleosome. 546 547 548 549 Next, we wanted to further validate our findings on the MEL enhancer logic using comparative 567
genomics. This allowed us, in addition, to test how turnover of TF binding sites affects enhancer 568 accessibility and function. To this end, we compared pairs of MEL enhancers that are homologous but 569
only accessible in one of the species, to investigate which mutations cause the collapse of a MEL 570 enhancer during evolution (Fig. 7a ). We focused only on pairs of highly probable orthologous enhancers 571 by requesting a stringent liftOver score (minimum of 99% of the bases must remap) and high sequence 572
identity (at least 80% of the bases must be identical). We calculated the loss in ATAC-seq signal and 573
in DeepMEL score, and aligned the sequence pairs to determine point mutations and indels between the 574 homologous sequences (Fig. 7a ). For example, an enhancer upstream of APPL2 is predicted as MEL 575 enhancer in the MEL dog line Cesar (topic 4 DL score of 0.35), whereas the orthologous enhancer in 576
human was completely closed (Fig. 7b ). Interestingly, not only the accessibility of the human homolog 577
was lost, but also the activity, as we confirmed by a luciferase assay (Fig. 7c) . Importantly, the 578
DeepMEL score for this enhancer was seven times lower in human than in dog, falling below the topic 579 4 significance threshold of 0.16, indicating that the model detected critical changes in the human 580 enhancer sequence that could explain the loss of this MEL enhancer. To determine which mutations 581
were causal for the loss in accessibility (and activity), we calculated the effect on the MEL prediction 582 score of each detected point mutation between the dog and human sequence, via in silico mutating the 583 dog sequence (see Methods, similar as in the IRF4 enhancer above). Several mutations seemed to alter 584 the DL score ( Fig. 7e,f) . To pinpoint the functional effect of each mutation, we plotted DeepExplainer 585 profiles and significant motif hits for CoRC factors on the original dog and human sequence (Fig. 7f ).
586
The functional dog enhancer contained a SOX10, MITF and TFAP2A binding site, which (almost) 587 disappeared in the non-functional human homologous sequence. The losses could be explained by one 588
T-to-A mutation in the SOX10 motif, one A-to-G mutation in the MITF motif and two mutations in the 589 TFAP2A motif (Fig. 7f, encircled mutations) . The SOX10 motif mutation had the strongest effect, as it 590 caused a 45% drop in the MEL-prediction score (Fig. 7e ). 591 592
Next, we performed this analysis on a larger scale, to globally study evolutionary changes in 593 accessibility of orthologous MEL enhancers between human and each of the other mammalian species 594 in our cohort. Firstly, we compared the topic 4 DeepMEL score for each pair of orthologous MEL 595 enhancers and observed that regions predicted as MEL in human but not in the other species were indeed 596 more accessible in human (Fig. 7g, I) ; in contrast, regions that were only predicted as MEL enhancers 597
in a non-human species were lowly accessible in human (Fig. 7g, II) . Orthologous regions that were 598
predicted as MEL enhancer in both human and another mammalian species were similarly accessible 599 in both species (Fig. 7g, III) . In fact, DeepMEL proved to be a good predictor for evolutionary changes 600 in accessibility, displaying a high correlation between the delta accessibility and the delta MEL 601
DeepMEL score between orthologous regions (Spearman's correlation of 0.429) ( Fig. 7h ). 602
Interestingly, we noticed that among the four CoRC factors, mostly the disruption or gain of one or 603 more SOX10 binding sites between orthologous enhancers quantitatively altered the ATAC-seq signal 604
in a negative and positive way, respectively (Fig. 7i, Fig. S7a ), indicating that SOX10 mutations are 605 most causal for changes in MEL enhancer accessibility. Indeed, in the example APPL2 enhancer 606
presented above, a detrimental mutation in the SOX10 binding site had the strongest effect on the MEL 607
DeepMEL score (Fig. 7e,f) , and thus likely, the most impact on not only the loss of enhancer 608 accessibility in human (Fig. 7b ), but also on the loss of enhancer activity (Fig. 7c ). However, this was 609 not the case for all MEL enhancers. For instance, an intronic enhancer of KIF1B was accessible and 610 predicted as MEL in human, but not in dog ( Fig. S7b,d) . Although the human region was accessible 611
and predicted as MEL, both the dog and the human enhancer showed no strong activity in a luciferase 612 assay ( Fig. S7c) . A deeper look at the enhancer code revealed that this human enhancer only contained 613 two significant SOX10 binding sites, but none of the other three CoRC players (Fig. S7e,f) . 614
Interestingly, by testing the activity of a total of six human or dog MEL-predicted enhancers, we could 615 distinguish two groups: enhancers that were only accessible and showed little activity (n = 3), or 616 enhancers that were both accessible and significantly more active (n = 3) ( Fig. 7j ). Profiling 617
DeepExplainer and significant motif hits revealed that the enhancers in the latter group all contained at 618 least one significant MITF binding site, while none of the enhancer in the former group did. Although 619 the number of tested enhancers is small, this trend, together with the fact that MEL enhancers containing 620 a MITF binding site showed increased H3K27ac signal (Fig. S5b) , indicates that MITF could function 621
as activator in MEL enhancers. Indeed, MITF has been shown to activate genes involved in 622 pigmentation by recruitment of co-factors and chromatin remodelling complexes 72 and was previously 623
classified as a TF involved in co-factor recruitment and activation based on its motif distribution in 624 nucleosome depleted regions 6 . Importantly, note that SOX10 binding is insufficient but appears 625 necessary for enhancer activity, as mutations in SOX10 binding sites disrupted enhancer activity in the 626 IRF4 (Fig. 3g ). 627 628
In conclusion, DeepMEL provides a suitable platform to study the effect of evolutionary mutations on 629
MEL enhancer accessibility and, in some cases, activity across species. Together, these results validate 630 that SOX10 is crucial for enhancer accessibility in MEL enhancers, and necessary but insufficient for 631 MEL enhancer activity, as activity appeared to be mainly dependent on MITF binding. 632 633 634 635 Here, we present an in-depth study of melanoma enhancer logic, especially in enhancers specific to the 672 MEL state, by exploiting both cross-species data and machine learning. Although the MEL and MES 673 melanoma cell state have been studied extensively on a transcriptomic and epigenomic level, the 674 combinatorial code of binding sites of their regulatory factors in state-specific enhancers has not yet 675 been explored. Understanding the enhancer logic and the mechanism by which TFs bind and direct 676 active enhancers will become increasingly important, as it will be essential for the development of new 677
therapies that either influence cell state-specific enhancer functions; for the use of (synthetic) enhancers 678 in a targeted way, i.e. enhancer therapy 73,74 ; or to prioritise non-coding variants in whole genome 679 sequencing studies of personal or cancer genomes (see our companion paper). 680 681
Predicting enhancers and determining their functional role within gene regulatory networks has been an 682 active field for years. Classically, ChIP-seq 1 , motif discovery tools 1, 8 'coordinator' motif predictive of species-biased cranial neural crest enhancers between human and 687 chimp. Despite the well-established power of cross-species approaches, to our knowledge, a large 688 comparative epigenomics study in melanoma has not yet been conducted, although several non-human 689 models are commonly used in melanoma research 34 . These have either been studied on an intra-species 690 level 33,75-80 ; in relation to human melanoma at the level of marker genes 30 , morphology and 691 pharmacological sensitivity 32 , transcriptome 81 ; or across three species in the context of genomic 692 landscapes 82 . Here, we conducted a comparative epigenomics study in melanoma across six species, 693
allowing us to demonstrate, for the first time, the conservation of not only the MEL cell state (and the 694 MES cell state in dog), but also the conservation of the underlying master regulators, based on 695 enrichment of TF binding sites within differential MEL and MES peaks and within conserved MEL 696 enhancers. 697 698
Although their proven advantages, sequence-based comparative approaches have limited power to 699 identify orthologous regulatory regions in distant species, in part because of the rapid evolution of distal 700 enhancers 83,84 . Methods, such as enhancer element locator (EEL), try to tackle this question by aligning 701
TF binding sites to identify conserved enhancer elements 85 , or by calculating the co-occurrence of 702 sequence patterns 61 . However, these methods are either supervised as they require user-provided PWMs 703 85 or are difficult to extract the important biologically-relevant features from 61 . In addition, the 704 identification and exact localisation of important (de novo) TF binding sites within enhancers is 705 complex as motif discovery tools are often dependent on user-provided databases and motif-specific 706 thresholds. Recently, deep learning approaches, which are commonly used in disciplines such as speech 707
recognition and image analysis, found their way into the regulatory genomics field to overcome these 708 concerns 15 , but have, to our knowledge, not yet been applied to evolutionary enhancer studies. As deep 709
learning models, such as DeepBind, are particularly powerful in learning complex patterns by 710 leveraging large epigenomics datasets, they are well suited to function as de novo motif detectors, as 711
well as to uncover more complex sequence features at higher-level layers that capture the internal 712 structure 15,16 . By designing DeepMEL, a multi-class multi-label neural network trained on melanoma-713 specific human regulatory topics of co-accessible regions, and by using the model interpretation tool 714
DeepExplainer 54,55 , we were able to perform a thorough and unsupervised analysis of important TF 715 binding sites in melanoma enhancers. Specifically, in MEL enhancers, our data suggests conserved co-716
binding of a Core Regulatory Complex of four main transcription factors, consisting of SOX10, 717 TFAP2A and MITF. DeepMEL also finds motifs for RUNX factors, but their role in the melocyte or 718 melanoma is less clear. Evidence for co-binding of SOX10, MITF, and TFAP2A was previously 719 observed by enrichment of both MITF and TFAP2A motifs in SOX10 ChIP-seq data in melanoma 720 cells 65 . To predict the precise location and the significance of these TF binding motifs, we designed a 721 new motif scoring scheme by multiplying DeepMEL convolution filters with DeepExplainer 722 profiles 54,55 . We observed high flexibility in the organisation of TF binding sites of the CoRC since 723 eight different modalities were found, formed by all permutations of the CoRC factors, with the 724 exception that all MEL enhancers contained at least one SOX10 binding site. MEL enhancers adhere to 725 a 'mixed modes enhancer' model, a billboard-like model with mostly high flexibility in the TF motif 726 organisation, except for the ever-present SOX10 binding sites 68 . Other cross-species studies of 727 enhancers have used ChIP-seq against TFs to examine conserved and divergent enhancers 10,86,87 . Here 728
we avoid the necessity of cross-species ChIP-seq data, as we approximate this by combining ATAC-729 seq and DeepMEL to characterise, in an unsupervised way, the conservation and divergence of 730 enhancers linked to several melanoma master regulators 731 732
It is well recognised that distinct functional classes of TFs exit, with respect to enhancer binding. 733
Pioneer TFs, such as OCT4, SOX2, GRHL, and FOXA1, are able to bind nucleosomal DNA, leading 734
to displacement of the nucleosome and facilitating the binding of other TFs to the accessible 735 enhancer 5,7,68 . SOX2, for example, was shown to bind nucleosomal DNA in vitro and associate with 736 closed chromatin 88-90 . SOX2 and other SOX factors have a HMG domain that interacts with the minor 737 groove of the DNA, causing the DNA to bend in a 60-70° angle, a property that has been suggested to 738 contribute to the pioneering activity of SOX2, and possibly of other SOXs 91 . There is still some dispute 739 on the pioneering properties of SOX TFs, as another study classified SOXs as 'migrant TFs', i.e. non-740
pioneering TFs that only bind sporadically to (non)-chromatinised DNA 92 . Nonetheless, we find strong 741 evidence for a pioneering function of SOX10 in MEL melanoma cells. Our current and previous study 29 742
have shown that knock-down of SOX10 induces closure of SOX10-bound ATAC-seq peaks containing 743 a SOX10 motif. In fact, DeepMEL predicts SOX10 binding sites as essential for MEL enhancer 744
accessibility. SOX10 is known to engage with open chromatin, as 98% of SOX10 ChIP-seq peaks 745 overlap with DNase-seq sites 57 and, in addition, SOX10 has been shown to physically interact with 746 BRG1, a subunit of the SWI/SNF chromatin remodeling complex, in differentiating melanocytes 93 . 747
Altogether, this supports the pioneering role of SOX10 in melanocytic melanomas. Notably, especially 748 the binding of SOX10 dimers appeared important for MEL enhancer accessibility as eight of the ten 749 enriched SOX10 DL filters in topic 4 represent a SOX10 dimer motif rather than a monomeric motif. 750 This is further supported by the fact SOXE proteins, such as SOX10, are known to form homo-and 751
heterodimers with other SOXE factors 94 . In addition, a study on SOX9, another member of the SOXE 752 TF family, showed that dimerisation of SOX9 was necessary to remodel the chromatin of a Col2a1 753 enhancer and to, eventually, allow its activation 95 . Interestingly, we also detected a positional specificity 754
for the SOX10 dimer binding sites as they are mainly localised within the nucleosomal DNA, around 755 40 bp inwards from the nucleosome start point. Although the findings from Zhu et al. support the 756 binding of SOX(10) proteins inside the nucleosome borders, they observe an enrichment of SOX10 757
binding towards the dyad of the nucleosome, more towards the center compared to our results reveal. 758
Therefore, further investigations of SOX10 binding to chromatinised DNA might improve the 759 resolution of the exact location of this TF with relation to the nucleosome start and middle point. 760 761
Next to pioneer factors, other functional classes of TFs exist, including factors that stabilise the 762 accessibility of the nucleosome depleted regions. TFAP2A was previously classified as such a 763 chromatin stabiliser 6 . Indeed, evolutionary divergence from the TFAP2A consensus motif correlates 764
with loss of chromatin accessibility and H3K27ac ChIP-seq signal 11 . These reports support our 765 observations of TFAP2A as a stabiliser of SOX10-dependent accessible MEL enhancers, likely due to 766 direct competition of TFAP2A with the nucleosome, as TFAP2A binding sites were highly enriched at 767 the predicted center of the central nucleosome. The dependence of SOX10 for opening MEL enhancers 768
prior to TFAP2A binding is in line with the reported classification of TFAP2A as a 'settler', a TF whose 769 binding depends predominantly on the accessibility of the chromatin at their binding sites 92 . 770 771
Besides classifying accessible (orthologous) regions and predicting important TF motifs within them, 772
DeepMEL is an accurate predictor of the effect of mutations on enhancer accessibility and, for some 773 enhancers, also the activity. This was for instance the case for the IRF4 MEL enhancer, where 774
DeepMEL performed best among the computational methods tested in Kircher et al.. Note however, 775
that the other models in the benchmark were trained to predict the activity of a total of 20 regulatory 776
regions ranging across different cell types; whereas our DL model is specialised for melanoma 777 regulatory regions. This demonstrates the value of using case-specific training data, such as the data set 778 generated in this study for melanoma. Interestingly, not all predicted MEL enhancers were in fact active. 779
Luciferase assays on a total of six MEL enhancers suggest that SOX10 alone is sufficient for enhancer 780 accessibility, but not for enhancer activity, as MITF binding seems to be needed to activate SOX10-781 dependent melanoma enhancers. The study of Fufa et al. supports this hypothesis, as activating SOX10-782 regions in mouse melanocytes showed significant enrichment of E-box motifs (bound by the bHLH 783
protein family, which includes MITF), indicating that it might cooperate with SOX10 to execute 784 melanocyte-specific gene activation. In addition, MITF was previously classified as a TF involved in 785 co-factor recruitment and activation 6,72 . Although SOX10 binding is not sufficient for enhancer activity, 786
it is necessary, as disruption of the SOX10 binding site in the IRF4 enhancer had a strong effect on 787 activity, probably due to the reappearance of the central nucleosome. Also in an enhancer located about 788 15 kb upstream of the MEL-specific gene tyrosinase in mouse, both Sox10 and Mitf binding sites were 789 required for activity 96 . This mode of action is also present in other cell types, such as epithelial cells in 790
Drosophila, where Grainyhead acts as pioneer TF and is necessary for both accessibility and activity of 791 epithelial enhancers, but not sufficient for their activity; where it was suggested that the TF Atonal, also 792 a bHLH factor like as MITF, could function as activator of Grh-dependent enhancers 7 . Note that the 793 human and pig predicted MEL enhancers were also accessible in human and pig melanocytes, 794
respectively, indicating that we possibly could extend these observations on the MEL enhancer logic to 795 enhancers in melanocytes. 796 797
In conclusion, the combination of comparative epigenomics with deep learning allowed us to perform 798 an in-depth analysis of the melanoma enhancer logic. This work presents an overall framework which 799
can be applied to decipher the enhancer logic in a cell type or cell state of interest, starting from the 800 generation of an extensive cell type-specific (cross-species) epigenomics dataset, all the way through 801
the training and exploitation of a deep neural network to decode enhancer features across species, and 802
to utilise it to assess the impact of cis-regulatory variation. 803
Methods
804
Cell culture 805 806
Human melanoma cell lines 807
Human melanoma cultures ("MM lines") are short-term cultures derived from patient biopsies 27,35 808 (Gembarska et al., 2012; Verfaillie et al., 2015) . Cells were cultured at 37°C with 5% CO2 and were 809 maintained in Ham's F10 nutrient mix (Thermo Fisher Scientific) supplemented with 10% fetal bovine 810 serum (FBS; Invitrogen) and 100 µg ml -1 penicillin/streptomycin (Thermo Fisher Scientific). 811
Zebrafish melanoma cell lines 812
Experiments were performed as outlined by Ceol et al. 97 . Briefly, 25 pg of MCR:EGFP were 813 microinjected together with 25 pg of Tol2 transposase mRNA into one-cell Tg(BRAFV600E);p53-/-; 814 mitf-/-zebrafish embryos. Embryos were scored for melanocyte rescue at 48-72 hours post-fertilisation, 815
and equal numbers were raised to adulthood (15-20 zebrafish per tank), and scored weekly (from 8-12 816
weeks post-fertilization) or bi-weekly (> 12 weeks post-fertilization) for the emergence of raised 817 melanoma lesions 31 . For in vitro culture, large tumors were isolated from MCR/MCR:EGFP (14-28 818 weeks post-fertilization). Zebrafish were maintained under IACUC-approved conditions. Zebrafish 819 primary melanoma ZMEL1 cell line was previously described 38,39 and EGFP 121-1, EGFP 121-2, EGFP 820 121-3, EGFP 121-5, were generated as described 98,99 . All cell lines were cultured in DMEM medium 821 (Life Technologies) supplemented with 10% heat-inactivated FBS (Atlanta Biologicals), 1X 822
GlutaMAX (Life Technologies) and 1% Penicillin-Streptomycin (Life Technologies), at 28°C, 5% CO2. 823
Zebrafish melanoma lines were authenticated by qPCR and Western for EGFP transgene expression, 824
and periodically checked for mycoplasma using the Universal Mycoplasma Detection Kit (ATCC). 825 826
Horse melanoma cell lines 827 
Dog melanoma cell lines 840
The dog cell lines Bounty and Cesar were established by Aline Primot 37 , and were derived from an 841 uveal melanoma from a Beagle crossed dog and an oral melanoma from the palate from a Shih-tzu, 842
respectively. Cells were cultured at 37°C with 5% CO2 in Ham's F-12 Nutrient Mixture medium 843
(Thermo Fisher Scientific) supplemented with 10% fetal bovine serum (FBS; Invitrogen) and 1% 844 penicillin/streptomycin (Thermo Fisher Scientific). 845
Mouse melanoma cell lines 846
The mouse melanoma cell line was generated as described in 36 number D-001810-10-05, Dharmacon) at a concentration of 20 nM for SOX10-KD, and 40 nM for 855
TFAP2A-KD and the control using as medium Opti-MEM (Thermo Fisher Scientific) and omitting 856
antibiotics. The cells were incubated for 72 h before processing. 857
OmniATAC-seq data generation, data processing and follow-up analyses 858 859
OmniATAC-seq on mammalian lines 860 861
OmniATAC-seq was performed as described previously 101 . Cells were washed, trypsinised, spun down 862 at 1000 RPM for 5 min, medium was removed and the cells were resuspended in 1 mL medium. Cells 863
were counted and experiments were only continued when a viability of above 90% was observed. 864 50,000 cells were pelleted at 500 RCF at 4°C for 5 min, medium was carefully aspirated and the cells 865
were washed and lysed using 50 uL of cold ATAC-Resupension Buffer (RSB) (see Corces horse: equCab2; for pig: susScr11; for mouse: mm10; for zebrafish: danRer10) and by applying the 906 parameters --alignIntronMax 1 and --aslignIntronMin 2. Mapped reads were filtered for quality using 907
SAMtools (v1.2) view with parameter -q4, sorted with SAMtools sort and indexed using SAMtools 908
index. Peaks were called using MACS2 (v2.1.2) callpeak using the parameters -q 0.05, --nomodel, --909 call-summits, --shift -75 --keep-dup all and with the genome size for the correct species in --g, and this 910
for each sample per species separately. Summits were extended by 250bp up-and downstream using 911 slopBed (bedtools; v2.28.0), providing the chromosome sizes for the specific species. Per sample, peaks 912
were normalised for the library size using a custom script and overlapping peaks were filtered using the 913 peak score (keeping the highest scoring peak). Normalised bedGraphs were produced by 914 genomeCoverageBed (as part of bedtools; v2.28.0) using as scaling parameter (-scale) 1E6/(number of 915 non-mitochondrial mapping reads). BedGraphs were converted to bigWigs by the bedtools suit 916 functions bedSort to sort the bedGraphs, followed by bedGraphToBigWig to create the bigWigs, which 917
were used in IGV for visualisation. 918
Homer on human and dog differential accessible peaks 919
First, merged bed files of human and dog ATAC-seq regions were converted to gff format. Count 920 matrices were produced by featureCounts (v1.6.5) using these gff files and bam files of 5 MEL and 5 921
MES lines for human, and gff and bam files of Cesar and Bounty for dog. Differential peaks were 922 identified using DESeq2 (v1.22.2, R v3.5.2) with a log2FC higher than 2 and a pAdj lower than 0.0005. 923
Homer 47 was performed on the differential regions using findMotifsGenome.pl, providing the 924 differential regions as a bed file and a fasta file of the human or dog genome, with parameters -mask, -925 size give and -len 6,8,10,11,12,17,18. 926
Defining sets of conserved ATAC-seq regions 927
Accessible regions of non-human species were converted to hg19 coordinates using liftOver (Kent-928 tools) by providing the appropriate liftOver chain (UCSC) and allowing a -minMatch=0.1. LiftOvered 929 regions were intersected with accessible peaks in human (accessible peaks of 5 MEL MM lines) using 930
intersectBed (bedtools, v2.28.0) with -f 0.6 and to define set of conserved regions across species, e.g. 931
conserved regions in across the six species were identified by the intersection of all liftOver bedfiles of 932 non-human species with the human accessible regions, maintaining only the coordinates with which all 933 six species overlapped. 934
Clustering of species based on conserved ATAC-seq regions 935
Per species, a count matrix was made on the conserved ATAC-seq regions (conserved in all mammalian 936 species or in all six species, as described above) by featureCounts (v1.6.5) using a gff file of the 937 conserved regions in the coordinates of the specific species and bam files for the specific species. Count 938 matrix of different species were merged and the final count matrix was CPM normalised (edgeR 939 v3.22.5, R v3.5.2), followed by quantile normalisation. A principal component analysis (PCA) on the 940 normalised count matrix was performed using irlba (v2.3.3, R v3.5.2) and the first two principal 941 components were used for visualisation. 942
Branch length scoring across species 943
Conserved ATAC-seq regions were identified as described above, and for each of the species, the set 944 of conserved regions was converted to the coordinate system per species and fasta sequences were 945
retrieved. All sequences were scored with our collection of 20,003 motifs using Cluster-Buster 102 with 946 parameters -m 0, -c 0 and -r 10000. For each motif, the highest CRM score per conserved sequence was 947 used to calculate the BLS across species according to (ref) . The branch length was taken from the 948 phylogenetic data from http://hgdownload.cse.ucsc.edu/goldenpath/hg19/phyloP100way/ (UCSC). The 949
sum of the BLSs for all the conserved sequences across the mammalian or all six species was used as a 950
total score for each motif. We normalised these scores by performing BLS on a shuffled variant of all 951 sequences by shuffleseq (EMBOSS, v6.6.0.0), keeping the same base-pair compositions and sequence 952 lengths, and subtracting the shuffled BLS from the true BLS pre motif. This corrected BLS per motif 953
represents the conservation of the motif across a set of conserved regions across a set of species. 954 955 cisTopic analysis to obtain sets of co-accessible regions in human OmniATAC-seq data 956
To apply cisTopic 29 , a tool for single-cell ATAC-seq analysis, we first simulated single cells form our 957
bulk OmniATAC-seq data on the 17 human melanoma lines via bootstrapping. Per cell line, 50 958 simulated single cell bam files were generated containing each 50,000 random reads that were 959 bootstrapped from the bulk bam files. These simulated single cell bam files were provided as input for 960 cisTopic (v0.2.0, R v3.4.1), together with the merged regions across all 17 samples, after removing 961 blacklisted regions (ENCODE). We ran cisTopic (parameters: α = 50/T, β = 0.1, burn-in 962 iterations = 500, recording iterations = 1,000) for models with a number of topics between 2 and 30 (2 963
by 2). The best model, containing 24 topics, was selected on the basis of the highest log-likelihood. 964
Topics were binarised using a probability threshold of 0.995, and performed motif enrichment analysis 965 with cisTarget 8 . 966 967
Deep Learning 968
Data preparation 969
Regions, which were obtained after peak calling for each baseline (as explained in Data processing of 970 human melanoma baseline OmniATAC-seq samples), were merged into one bed file and overlapping 971 regions were removed via custom script. Before intersecting this merged peak file with topics to label 972 each region, regions were augmented in order to have more training data for DeepMEL by extending 973 them to 700 bp and sliding a 500 bp window over them with a 10 bp stride, which meant that each 500 974 bp augmented region still contained the ATAC-seq summit. Each augmented region had at least 400 bp 975 overlap with its origin. This augmented master region file was intersected with each topic file separately 976 via bedtools and each region was labelled with the topic number if there was an at least 60% overlap. 977 melanoma cell line, one pig melanocyte cell lines and one mouse melanoma cell line; ATAC-seq data 1155 of four zebrafish cell lines and OmniATAC-seq data of SOX10 and TFAP2A knock-down in the human 1156 melanoma cell line MM001. 1157
